Find out more about the members of TAC D by reading their biographies.
Professor Gary McVeigh (Chair)
Professor of Cardiovascular Medicine, Queen's University Belfast and Consultant Physician, Belfast Health and Social Care Trust
Gary is a Consultant Physician/Clinical Pharmacologist in the Belfast Health and Social Care Trust and Professor of Cardiovascular Medicine at Queen's University Belfast. Gary qualified from Queen's University and trained in Belfast and Minneapolis, USA.
His major clinical and academic interests relate to cardiovascular complications associated with hypertension, diabetes mellitus and hyperlipidaemia. He has served as a member of the Executive Committee of the British Hypertension Society and is currently a member of the Guidelines and Information Committee. Gary was Regional Advisor for Northern Ireland and member of council for the Royal College of Physicians of Edinburgh. Gary chairs the Drugs and Therapeutics and New Drugs Committees and is the lead clinician for Therapeutic reviews in the Belfast Trust. He is the Training Programme Director for Clinical Pharmacology and Therapeutics in Northern Ireland.
Gary was former Vice Chair of Technology Appraisal Committee C and is currently Standing Chair of an internal Guideline Development Group for NICE.
Dr Lindsay Smith, BSc MClinSci PhD MD FRCP FRCGP FHEA (Vice Chair)
General Practitioner, Westlake Surgery, Somerset
Lindsay Smith has been a General Practitioner in Somerset for over 25 years. During this time he has undertaken primary care research through both academic departments and research general practices. He has previously been a Consultant senior lecturer in general practice and primary care. Currently he is an honorary senior lecturer at Bristol University, a CCG Patient Safety Lead.
He has previously worked for NICE as a member of its TA appeals committee, its QOF advisory committee and various GDGs. Additionally he has been a member of its Quality Standards Advisory Committee, its CG Rapid Updates Standing Committee and a member of its Suspected Cancer GDG.
Dr Nabeel Alsindi
GP Clinical Lead for Primary care, Doncaster CCG
Nabeel has worked as a General Practitioner and Commissioner in Doncaster since 2014. He qualified from Oxford University in 2009 and has worked in various hospitals and GP surgeries across Sheffield and Doncaster.
After finishing his GP training, Nabeel undertook a Commissioning Fellowship. This has led to a permanent role with Doncaster Clinical Commissioning Group as Clinical Lead for Primary Care and Long Term Conditions. He sits on the CCG's Primary Care Commissioning Committee and provides a wider primary care perspective into a number of forums both within and external to the CCG. He is also a member of the Yorkshire & Humber Clinical Senate Assembly.
Mr James Avery
Director of Nursing, Barking, Havering and Redbridge University Hospitals NHS Trust
James leads the portfolios of patient experience, engagement, safe staffing and innovation in practice at Barking, Havering and Redbridge University Hospitals NHS Trust. He completed registered nurse education in 1995 and worked within the specialties of cardiology and acute medicine combining clinical and leadership roles with quality improvement and clinical simulation. James has developed expertise in the area of clinical governance, quality improvement and practice innovation. He has worked alongside commissioners, providers of services and patients to co-design improvements across a range of services and sees this as essential for delivering safe and patient focussed care.
James holds a strong interest and commitment to data analysis and clear presentation in ways that inform and direct practice. Most recently James has led the implementation of an electronic observation and deterioration detection system within a large acute hospital and worked with the Royal College of Physicians Mortality team to deliver a case review process. He sees membership of the technology appraisal committee as an excellent opportunity to contribute further to the evaluation of clinical innovation.
Professor David Bowen, MA MB BChir MD MRCP FRCPath
Consultant Haematologist, Leeds Teaching Hospitals NHS trust
David qualified from Cambridge University and Middlesex Hospital, London. He trained in Haematology in London and Cardiff, with first his Consultant appointment in Dundee,then in Leeds where he has worked since 2005. His clinical expertise is in myeloid malignancies, with research interests in the etiology, molecular basis and clinical trial management of these diverse and rare cancers.
He has chaired the National Cancer Research Institute Myelodysplastic Syndromes (MDS) subgroup and the British Committee for Standards in Haematology Guideline group for MDS. He co-chairs the European Myelodysplastic Syndrome Registry programme, accruing data for clinical effectiveness of management interventions in community-based practice.
Value Evidence & Outcomes, Global Therapy Area Head for Immuno-Inflammation
Biography coming soon.
Professor of Health Technology Assessment, University of York
Biography coming soon.
Professor Rachel Elliott
Professor of health economics, University of Manchester
Rachel is a professor of health economics in the Manchester Centre for Health Economics at the University of Manchester. She is also the co-director of the Manchester Clinical Trials Unit and a UK registered pharmacist. She has many years of experience in applied health economics research across a range of disease areas. Study designs include patient and practice-level cluster trials, stepped-wedge designs, quasiexperimental methods supported by large database and routine data interrogation, economic modelling and simulation, close working with clinical and patient expert panels. and use of routine data.
She is one of the academic leads for Datalab, a University of Manchester, Health Innovation Manchester and NICE collaboration to develop the use of routine data to develop and evaluate guidelines and digital health technologies. She has been member of a NICE technology appraisal committee since 2006.
Gillian Ells, BPharm PGDip MSc
Prescribing Advisor - Commissioning. Hastings and Rother Clinical Commissioning Group and Eastbourne, Hailsham and Seaford Clinical Commissioning Group
Gillian Ells is a pharmacist working for two clinical commissioning groups on the south east coast of England. Her previous experience includes working in both the hospital and the community sector.
She has spent the past 16 years in primary care as a pharmaceutical advisor and now specialises in the commissioning of new drug treatments and management of the local health economy drug formulary. Gillian has recently completed a Masters in Health Economics and Health Policy at Birmingham University.
Professor Paula Ghaneh
Professor and Honorary Consultant Surgeon, University of Liverpool
Paula Ghaneh is a Professor of Surgery at the University of Liverpool and an Honorary Consultant Surgeon at the Royal Liverpool University Hospital.
Her clinical specialty is hepato-pancreato-biliary surgery. Her research interests are pancreatic cancer and clinical trials. She is the Deputy Director of the Cancer Research UK Liverpool Cancer Trials Unit. She is a member of the NCRI upper GI CSG and pancreatic cancer subgroup.
Dr Peter Hall
Senior Clinical Lecturer in Medical Oncology, University of Edinburgh
Peter Hall is an academic Medical Oncologist with a research interest in and Health Economics and Health Technology Assessment in Cancer. He treats patients with breast cancer at the Edinburgh Cancer Centre and leads the Health Economics Group within the University of Edinburgh Clinical Trials Unit.
He graduated from the University of Edinburgh Medical School in 2003, undertaking general medical training in Fife and Dundee then specialist training in Medical Oncology with the Yorkshire Deanery in 2006. He undertook at NICE scholarship in 2007 and completed a PhD in Health Economics and Clinical Trial design at the University of Leeds in 2012.
The focus of his research is on the development of improved methods for efficient research design, cost-effectiveness analysis and the measurement of clinical and socioeconomic outcomes using data obtained from research and routinely collected within the NHS.
Rebecca works as an independent public and patient adviser for a number of universities and research institutions within the UK. She is a member of both PPIREs and INSPIRE, which are Norfolk-based public and patient involvement groups involved in scientific research and mental health projects. Rebecca sits on a number of research committees as a Lay Member including the Health Technology Assessment Women and Child's Health Panel, the Research for Patient Benefit East of England Committee and is also a member of the NHS Patient and Public Voices Group.
Rebecca has a strong interest in medical and scientific research and a background in academic research, scientific review and ethics. She has completed a PhD and Masters by Research degree in Biological Sciences, and has worked as a Scientific Officer for Cancer Research UK for seven years and Biochemistry at Cambridge University for three years.
Dr Andrew Hitchings
Senior lecturer in clinical pharmacology, St George's, University of London and honorary consultant in neurointensive care, St George's University Hospitals NHS Foundation Trust
Andrew trained in clinical pharmacology, general (internal) medicine, and intensive care medicine in London. In addition to his clinical training, Andrew gained substantial experience in clinical trials research, medicines management, and medical education.
Since 2016, Andrew has practised as an intensive care consultant in a busy regional neurointensive care unit at St George’s Hospital, London, where he also chairs the trust’s drugs and therapeutics committee. He is chief examiner for the final year of the medicine programme at St George’s, University of London, and leads teaching in clinical pharmacology and prescribing.
He is a member of the assessment board for the UK Prescribing Safety Assessment and chairs a question writing group for the Membership of the Royal College of Physicians written examinations.
Dr Robert Hodgson
Research Fellow, Centre for Reviews and Dissemination, University of York
Biography to follow.
Dr Bernard Khoo
Senior Clinical Lecturer, Endocrinology, University College London and Royal Free London NHS Trust
Dr Khoo originally trained in the University of Cambridge and obtained a Ph.D. in Zoology as part of the M.B. PhD. Programme. He then obtained his specialist accreditation in Endocrinology and Diabetes at St Bartholomew’s Hospital, during which time he was appointed Wellcome Trust Advanced Fellow from 2003-2006. Since 2009, he has been appointed as Senior Clinical Lecturer and Honorary Consultant in Endocrinology at UCL Medical School and Royal Free Hospital.
His particular specialist interests are in adrenal neuroendocrinology and neuroendocrine tumours, as well as genetic endocrine disorders. He is the lead endocrinologist for the ENETS Centre of Excellence Royal Free Neuroendocrine Tumour Multidisciplinary Team.
Dr Soo Fon Lim
GP Consultant in Public Health
Soo Fon qualified from the University of Calgary (Canada) in 2004 after which he undertook Public Health and General Practice training in the UK, obtaining CCTs in both specialties.
He is passionate about population health, and specifically utilising evidence-based data to commission effective healthcare. He also enjoys being on the frontline of primary care.
He is currently a GP partner in Birmingham and also the Clinical Lead for Urgent Care Transformation at Birmingham and Solihull CCG.
Dr Guy Makin
Senior Lecturer in Paediatric Oncology, Royal Manchester Children’s Hospital
Guy trained in paediatric oncology in Bristol, Sheffield and Manchester, and completed a PhD in molecular pharmacology of neuroblastoma at the University of Manchester. Since 2002 he has been a clinical senior lecturer and honorary consultant paediatric oncologist at Royal Manchester Children’s Hospital.
Guy is a member of the NCRI Children’s Cancer and Leukaemia Clinical Studies Group, and is the national lead for the Paediatric Experimental Cancer Medicines Centre network. Guy is particularly interested in ensuring equity of access to novel treatments across the UK, and in bringing new drugs for children to the clinic more rapidly.
Health Economics Manager, Roche Diagnostics
Biography coming soon.
Dr David Meads
Associate Professor, Health Economics, University of Leeds
David Meads is a health economist in the Academic Unit of Health Economics, University of Leeds. He has many years of experience conducting economic evaluations alongside clinical trials, decision-analytic modelling and stated preference studies. David leads the Economic Evaluation for HTA module on the AUHE Health Economics MSc and supervises several PhD students. He regularly contributes to the NIHR Research Design Service.
Dr Libby Mills
Principal Therapeutic Radiographer, The Christie NHS Foundation Trust
Libby is part of the operational team managing the radiotherapy department in treatment section at The Christie NHS Foundation Trust. She trained at The Christie and then worked at St Bartholomew's Hospital, Guy's & St Thomas' Hospital and University College Hospital before returning to The Christie. She holds an MSc in Radiotherapy from Sheffield Hallam University.
Libby also works as a specialist advisor for the CQC (radiography) and has served on the Society of Radiographers National Radiotherapy Advisory Group.
Chief Pharmaceutical Officer’s Fellow, Public Health England
Olaolu is a qualified pharmacist with a Master of Public Health with a specialism in health economics. He is currently the Chief Pharmaceutical Officer’s Fellow at Public Health England, working within the antimicrobial resistance (AMR) programme. His work focusses on addressing the challenges of AMR through extracting insights from surveillance data and research on prescribing behaviours.
Previously he was the clinical lead for primary care variation for Medway CCG. With a background in local commissioning, he has led on some population health management projects to improve patient access and health outcomes.
Dr Malcolm Oswald
Malcolm works as an independent consultant. His background is in systems analysis, analysing what people and organisations providing health care do and also what information they need to do it. Since the late 1990s, he has specialised in information governance, working mostly for National bodies in England and Scotland specifying the rules that control who accesses confidential patient information in systems. This involves interpreting and applying law and policy, consulting clinicians and patient/public representatives.
Malcolm has completed a PhD in Bioethics and Medical Jurisprudence. His thesis explores how, in a democracy, we should decide how resources are allocated to health care, analysing competing theories from philosophy, economics and other disciplines. In 2011, he co-authored the Royal College of General Practitioners' guidance on ethical commissioning (“Making Difficult Choices”).